NewsBenzingaNeedham Reiterates Underperform on Sarepta Therapeuticsto Underperform Needham Reiterates Underperform on Sarepta Therapeuticsto Underperform Benzinga 2026.09.28 10:14 (GMT+0) Open on Benzinga Other news Circle plans to enter about 40 emerging and developing markets Vitalik Shows Off AI Agent "Privacy Mode": Integrating Tor, zkAPI and Local LLM Mastercard and BVNK Launch Global Money Platform, Integrating Fiat and Stablecoin Payments Zebra Technologies Q3 2026 Earnings: What to Expect Earnings Preview: What to Expect From Lumentum’s Report Marriott International's Q3 2026 Earnings: What to Expect
